Nina Feldman

We’re more cautious about people and places after the last 24 months. And for better or worse, some changes we’ve made seem likely to stick.

Penn researcher Drew Weissman spent decades developing mRNA technology. He says it helps target the rapidly mutating human immunodeficiency virus.

The CDC's shift reflects a substantial drop in COVID-19 cases nationwide.

A complaint filed by Attorney General Josh Shapiro asserts Doroshin violated consumer protection, charitable solicitation, and nonprofit laws.

The nonprofit has been battling for years with the U.S. Justice Department to open a supervised injection site in Philadelphia.

Symptoms can hang on for a while. Maybe longer than you expect, as a reporter for WHYY’s Health Desk Help Desk learned.

The pilot program for distributing the overdose-reversing drug is funded by a grant from the Centers for Disease Control and Prevention.

For a Philadelphia physician, rest seemed out of the question during the early part of the pandemic. But she learned an important lesson about the need to slow down.

City health officials announced earlier this year they had given out more than 260,000 booster doses since August. This is how the numbers break down.

The new oral meds are in short supply around Philly, but doctors aren’t prescribing what’s available. Timing and risks are part of the equation.

Cases are down from their peak around Jan. 9, city Health Commissioner Bettigole said. Hospitalizations, which lag new cases, are up.

The website appears not to recognize some residences within multi-unit buildings as individual households.